Covid antiviral pill molnupiravir/Lagevrio set for UK at-home trials

The first at- home treatment for Covid-19 could be offered to UK patients before Christmas as an attempt to protect the most vulnerable from the Omicron variant.

The Sunday Telegraph reported that Sajid Javid is going to launch a national pilot of the pill.

The newspaper said that the plans called for the delivery of the tablets to vulnerable patients within 48 hours if they were positive for Covid.

It was reported that a series of Covid medicines delivery units were being established to ensure that the treatment gets to patients as quickly as possible once it is confirmed that they have the virus.

[.

The UK is the first to approve the use of molnupiravir.

The UK is the first to approve an oral anti-viral pill.

The UK became the first country in the world to license its use last month.

Prof Chris Whitty, England's chief medical officer, warned last week that it may have to be reconsidered. I think we need to rethink it just to make sure we are targeting in the right direction with the new variant.

The UK has proven itself to be a world leader in identifying and rolling out effective treatments for Covid-19, according to a Department of Health and Social Care spokesman.

The government launched a task force to find treatments for UK patients who have been exposed to Covid-19 to take at home.

There are a number of exciting opportunities in the works.